DLA Piper has advised Resmed. Wilson Sonsini Goodrich & Rosati has advised Noctrix Health. Resmed has completed the acquisition of Noctrix Health, Inc. for $340 million,...
Resmed Acquires Noctrix Health for $340 Million to Expand Sleep Health Portfolio
ResMed v. NYU
Allen & Overy’s U.S. IP Technology Disputes team achieved a significant victory for ResMed. ResMed, a global leader in digital health technology and sleep and respiratory...
ResMed’s $1 Billion Acquisition of MediFox Dan
Latham & Watkins has advised Hg on the deal, while DLA Piper has advised ResMed. Poellath advised the management of Medifox Dan. Dechert advised BC Partners....



























